frontier-banner
Frontiers
Home>Frontiers>

Signal Transduction and Targeted Therapy | Spatial Organization of the CXCL12-CXCR4 Fibroblast-Immune Niche and Convergence of Autoimmune Signatures in Chronic Antibody-Mediated Rejection

Signal Transduction and Targeted Therapy | Spatial Organization of the CXCL12-CXCR4 Fibroblast-Immune Niche and Convergence of Autoimmune Signatures in Chronic Antibody-Mediated Rejection
--

This study reveals the spatial distribution patterns of key immune cell subsets in chronic antibody-mediated rejection (CAMR), providing a direct theoretical basis for designing intervention strategies targeting the CXCR4 pathway and developing novel autoimmune disease models.

 

Literature Overview

The article titled "Autoimmune-shared immune states converge in a CXCL12–CXCR4 fibroblast–immune niche in chronic antibody-mediated rejection," published in Signal Transduction and Targeted Therapy, systematically explores how circulating immune states connect with spatially organized injury within the transplanted kidney in chronic antibody-mediated rejection (CAMR). It further analyzes whether these immune signatures are recapitulated in systemic autoimmune diseases. The study integrates single-cell transcriptomics, spatial transcriptomics, and multi-omics data to depict a unique immune remodeling map specific to CAMR.

Background Knowledge

Chronic antibody-mediated rejection (CAMR) is the leading cause of late graft loss in kidney transplantation, characterized pathologically by donor-specific antibodies, microvascular inflammation, and progressive fibrosis. Current clinical challenges include the lack of circulating biomarkers capable of accurately predicting late-stage rejection and an incomplete understanding of the mechanisms by which immune cells are recruited and localized to specific injury sites (e.g., perivascular regions) within the graft. While B cells and plasma cells play a central role in CAMR, recent studies suggest that the inflammatory ecosystem comprising myeloid cells, T cells, and NK cells is equally critical. Furthermore, CXCR4, as a key chemokine receptor, has been a research bottleneck regarding its spatial regulatory role in chronic inflammation. This study focuses on identifying the key molecular axis connecting circulating immune remodeling with local tissue injury through cross-tissue (blood and graft) and cross-disease (transplant rejection and autoimmune diseases) comparative analyses, specifically investigating the spatial organizational role of the CXCL12-CXCR4 axis within the fibroblast-immune cell niche.

 

 

Research Methods and Core Experiments

The authors constructed single-cell atlases of peripheral blood and kidney grafts from patients with CAMR, those with stable allograft function (SAF), and healthy controls. The study employed a multi-omics integration strategy, including single-cell RNA sequencing (scRNA-seq), spatial transcriptomics (Visium HD), multiplex immunofluorescence (mIF), and spectral flow cytometry. Key evidence was generated by screening for CAMR-specific enriched cell subsets using a large-scale blood immune reference dataset and precisely localizing these subsets to perivascular regions within the graft using spatial transcriptomics. Additionally, spatial transcriptomic data from rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) were compared to validate the cross-disease reproducibility of these immune niches.

Key Conclusions and Perspectives

  • Reproducible expansion of myeloid cells was identified in CAMR, particularly the SLC8A1+ monocyte/macrophage subset, which highly expresses CXCR4 and ZEB2. This suggests that this subset possesses migratory and inflammatory activation characteristics, serving as key effector cells linking circulating inflammation to graft injury.
  • ANK3+ CD4+ memory T cells and ZEB2hi T cells were identified as CAMR-specific enriched subsets. These cells are located near VCAM1+ endothelial cells in the tissue and express GZMB, indicating their direct involvement in the endothelial injury process.
  • CD16+ NK cells were found to be significantly enriched in CAMR grafts, exhibiting cytotoxic programs that interact with endothelial cells. Their transcriptional signature shows a progressive activation state in the blood.
  • Fibroblasts expressing CXCL12 and immune cells expressing CXCR4 were confirmed to form a tight niche around graft vessels. This structure is partially recapitulated in the inflamed tissues of RA and SLE, indicating a cross-disease mechanism of chronic inflammatory tissue organization.
  • Although B cells and plasma cells showed no significant proportional changes in the blood, they exhibited enrichment of IgG plasma cells and upregulated CXCR4 locally within the graft, suggesting their participation in local antibody-mediated injury guided by local chemokine gradients.

Research Significance and Prospects

These findings offer significant guidance for drug development, suggesting that targeting the CXCL12-CXCR4 axis or SLC8A1+ myeloid cells could become a new strategy for treating chronic rejection. In terms of clinical monitoring, specific immune subsets in peripheral blood (such as CXCR4+ myeloid cells) may serve as early warning biomarkers. Furthermore, this study provides a new perspective for disease modeling, indicating that when constructing models for autoimmune diseases or transplant rejection, attention should be focused on the construction of perivascular fibroblast-immune cell niches to simulate the authentic chronic inflammatory microenvironment.

 

 

Conclusion

Through multi-omics integration analysis, this study successfully linked peripheral circulating immune states with spatially organized injury in chronic kidney transplant rejection, revealing the central role of the CXCL12-CXCR4 fibroblast-immune niche. This discovery not only elucidates the recruitment and activation mechanisms of myeloid cells, T cells, and NK cells in CAMR but also demonstrates the universality of this inflammatory tissue pattern in autoimmune diseases. Translating from the laboratory to clinical practice, this study emphasizes the decisive role of the spatial microenvironment in chronic inflammation, providing a solid theoretical foundation for developing precise immunotherapies targeting specific cell subsets and chemokine axes. In the future, intervention strategies targeting this niche are expected to improve the prognosis of chronic antibody-mediated rejection and provide a new paradigm for investigating the pathological mechanisms of autoimmune diseases such as systemic lupus erythematosus, thereby fundamentally enhancing the standard of care for related diseases.

 

Reference:
Xuyang Xia, Yangjuan Bai, Binqi Yang, Heng Xu, and Lanlan Wang. Autoimmune-shared immune states converge in a CXCL12–CXCR4 fibroblast–immune niche in chronic antibody-mediated rejection. Signal Transduction and Targeted Therapy.
Post-translational modifications (PTMs) are key regulators of protein function, stability, and interactions, and are critical in cellular signaling, localization, and disease mechanisms. However, experimental identification of PTMs (e.g., mass spectrometry, western blotting, radioactive labeling) is costly and time-consuming, making computational approaches attractive alternatives. Traditional computational models rely only on local sequence features around PTM sites. Many existing pretrained protein language models (PLMs) are sequence-only, lack structural information, and are often single-task, preventing feature sharing across PTM types and limiting knowledge transfer and prediction performance.